TY - JOUR
T1 - Cognitive motor interference for gait and balance in stroke: A systematic review and meta-analysis
AU - Wang, Xueqiang
AU - Pi, Yanlin
AU - Chen, B
AU - Chen, Peijie
AU - Liu, Yu
AU - Wang, Ru
AU - Li, X
AU - WADDINGTON, Gordon
N1 - © 2015 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Background and purpose: An increasing interest in the potential benefits of cognitive motor interference (CMI) for stroke has recently been observed, but the efficacy of CMI for gait and balance is controversial. A systematic review and meta-analysis of randomized controlled trials was performed to estimate the effect of CMI on gait and balance in patients with stroke. Methods: Articles in Medline, EMBASE, the Cochrane Library, Web of Science, CINAHL, PEDro and the China Biology Medicine disc were searched from 1970 to July 2014. Only randomized controlled trials examining the effects of CMI for patients with stroke were included, and no language restrictions were applied. Main outcome measures included gait and balance function. Results: A total of 15 studies composed of 395 participants met the inclusion criteria, and 13 studies of 363 participants were used as data sources for the meta-analysis. Pooling revealed that CMI was superior to the control group for gait speed [mean difference (MD) 0.19 m/s, 95% confidence interval (CI) (0.06, 0.31), P = 0.003], stride length [MD 12.53 cm, 95% CI (4.07, 20.99), P = 0.004], cadence [MD 10.44 steps/min, 95% CI (4.17, 16.71), P = 0.001], centre of pressure sway area [MD -1.05, 95% CI (-1.85, -0.26), P = 0.01] and Berg balance scale [MD 2.87, 95% CI (0.54, 5.21), P = 0.02] in the short term. Conclusion: Cognitive motor interference is effective for improving gait and balance function for stroke in the short term. However, only little evidence supports assumptions regarding CMI's long-term benefits.
AB - Background and purpose: An increasing interest in the potential benefits of cognitive motor interference (CMI) for stroke has recently been observed, but the efficacy of CMI for gait and balance is controversial. A systematic review and meta-analysis of randomized controlled trials was performed to estimate the effect of CMI on gait and balance in patients with stroke. Methods: Articles in Medline, EMBASE, the Cochrane Library, Web of Science, CINAHL, PEDro and the China Biology Medicine disc were searched from 1970 to July 2014. Only randomized controlled trials examining the effects of CMI for patients with stroke were included, and no language restrictions were applied. Main outcome measures included gait and balance function. Results: A total of 15 studies composed of 395 participants met the inclusion criteria, and 13 studies of 363 participants were used as data sources for the meta-analysis. Pooling revealed that CMI was superior to the control group for gait speed [mean difference (MD) 0.19 m/s, 95% confidence interval (CI) (0.06, 0.31), P = 0.003], stride length [MD 12.53 cm, 95% CI (4.07, 20.99), P = 0.004], cadence [MD 10.44 steps/min, 95% CI (4.17, 16.71), P = 0.001], centre of pressure sway area [MD -1.05, 95% CI (-1.85, -0.26), P = 0.01] and Berg balance scale [MD 2.87, 95% CI (0.54, 5.21), P = 0.02] in the short term. Conclusion: Cognitive motor interference is effective for improving gait and balance function for stroke in the short term. However, only little evidence supports assumptions regarding CMI's long-term benefits.
KW - Balance
KW - Cognitive motor interference
KW - Dual task
KW - Gait
KW - Stroke
KW - Systematic review
KW - Humans
KW - Gait/physiology
KW - Postural Balance/physiology
KW - Combined Modality Therapy/methods
KW - Stroke/therapy
KW - Cognitive Behavioral Therapy/methods
KW - Exercise Therapy/methods
UR - http://www.scopus.com/inward/record.url?scp=84922605974&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/cognitive-motor-interference-gait-balance-stroke-systematic-review-metaanalysis
U2 - 10.1111/ene.12616
DO - 10.1111/ene.12616
M3 - Article
C2 - 25560629
SN - 1351-5101
VL - 22
SP - 555-e37
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 3
ER -